Skip to main content
TipRanks
Go Ultimate75% OFF

Newton Charles W. Insider Profile

11 Followers

Newton Charles W., Director at Keros Therapeutics, holds 12.11K shares in Keros Therapeutics (Ticker: KROS), holds 30.00K shares in Coherus Biosciences (Ticker: CHRS), holds 9.52K shares in Novavax (Ticker: NVAX).

Newton Charles W.'s Trading History

KROS
Keros Therapeutics
Aug 20, 2026DirectorUninformative Sell5.68K$124.77K
CHRS
Coherus Biosciences
Jun 09, 2026DirectorUninformative Buy―$15.75K
NVAX
Novavax
Apr 28, 2026DirectorUninformative Buy78.25K$81.16K
LYEL
Lyell Immunopharma
Aug 22, 2025CFOUninformative Buy―$361.88K
TSVT
2seventy bio
Jun 12, 2024―Uninformative Buy―$113.13K

You May Also Like

Newton Charles W. insider profile FAQ

What is the percentage of profitable transactions made by Newton Charles W.?
The percentage of profitable transactions made by Newton Charles W. is 33%.
What is the average return per transaction made by Newton Charles W.?
The average return per transaction made by Newton Charles W. is -19.70%.
What stocks does Newton Charles W. hold?
Newton Charles W. holds: KROS, CHRS, NVAX, LYEL, TSVT stocks.
What was Newton Charles W.’s latest transaction?
Newton Charles W.’s latest transaction was an Uninformative Sell of $5.68K.
What was Newton Charles W.'s most profitable transaction?
Newton Charles W.’s most profitable transaction was an Informative Buy of LYEL stock on March 18, 2025. The return on the trade was 11.90%.
What is Newton Charles W.'s role in Keros Therapeutics?
Newton Charles W.'s role in Keros Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.